Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

13 trials with published results (9%)

Research Maturity

82 completed trials (54% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.9%

6 terminated out of 152 trials

Success Rate

93.2%

+6.7% vs benchmark

Late-Stage Pipeline

13%

20 trials in Phase 3/4

Results Transparency

16%

13 of 82 completed with results

Key Signals

13 with results93% success

Data Visualizations

Phase Distribution

120Total
Not Applicable (71)
Early P 1 (1)
P 1 (13)
P 2 (15)
P 3 (11)
P 4 (9)

Trial Status

Completed82
Unknown38
Recruiting11
Terminated6
Active Not Recruiting5
Withdrawn5

Trial Success Rate

93.2%

Benchmark: 86.5%

Based on 82 completed trials

Clinical Trials (152)

Showing 20 of 20 trials
NCT06885697Phase 1Recruiting

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

NCT05855200Phase 3RecruitingPrimary

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

NCT07173985Not ApplicableRecruitingPrimary

Strategies for Optimizing a Mailed FIT Program in Appalachia

NCT00579163Active Not Recruiting

Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers

NCT05773144Not ApplicableRecruitingPrimary

Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer

NCT07314996Not ApplicableNot Yet RecruitingPrimary

Laparoscopic Versus Open Surgery for Colon Cancer With Visceral Obesity

NCT03619538Not ApplicableCompletedPrimary

Interest of the Nefopam and PCA Morphine Combination for Postoperative Analgesia in Patients Undergoing Colon Surgery

NCT04780256Recruiting

Endoscopic Resection of Gastrointestinal Neoplasms

NCT02151123WithdrawnPrimary

Metabiomics Colon Cancer Clinical Research Study

NCT06124378Phase 2Active Not RecruitingPrimary

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

NCT07132008Phase 3Not Yet RecruitingPrimary

Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer

NCT05619614CompletedPrimary

The Influence of Artificial Intelligence (AI )Assisted Polyp Detection (Discovery System) on Visual Gaze Patterns During Real-time Colonoscopy

NCT05789433Not ApplicableRecruitingPrimary

Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer

NCT03037385Phase 1Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT00843375RecruitingPrimary

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

NCT05500248Not ApplicableCompletedPrimary

Artificial Intelligence for Leaving in Situ Colorectal Polyps.

NCT04441580Not ApplicableCompletedPrimary

Assessing the Additional Neoplasia Yield of Computer-aided Colonoscopy in a Screening Setting

NCT06910514Phase 3Completed

Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions

NCT04906343Not ApplicableCompleted

Endoscopic Surveillance in Serrated Polyposis Syndrome and Low-risk of Advanced Neoplasia

NCT06792292Not ApplicableNot Yet Recruiting

Artificial Intelligence-Assisted Colonoscopy in Colorectal Cancer Screening in a General Hospital

Scroll to load more

Research Network

Activity Timeline